TigerText, Honeywell to partner on app focused on patient information

TigerText will partner with Honeywell to develop an app to will allow healthcare providers to scan a patient’s barcode and retrieve up-to-date information about the patient’s medications, care team and recent procedures directly from their electronic medical record (EMR) through a Honeywell smartphone.

“We’re excited to work with Honeywell to bring the rapidly expanding number of connected clinicians an innovative bot-driven solution for quickly accessing EMR data from a patient’s bedside,” said Brad Brooks, TigerText co-founder and CEO. “With rising healthcare costs it is essential that providers find ways to lower overhead and drive efficiencies. Messenger bots offer an exciting new avenue for automating tasks, accessing organizational data in real time, increasing patient satisfaction, and improving the bottom line.”

Using the scanner from Honeywell's Dolphin CT50h smartphone to verify a patient’s identity to pull information directly from the EMR system, the app will be able to securely send and receive protected health information (PHI) as well as other data necessary for making care decisions. The app also ensures users comply with the Health Insurance Portability and Accountability Act (HIPAA) and Joint Commission criteria.

“As text messaging becomes more commonplace in healthcare, nurses need a quick and reliable method to communicate with hospital staff in order to provide their patients with quality care,” said Kirk Heyde, vice president, Honeywell Sensing and Productivity Solutions.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?